Evidence map›Paper›PMID 23090966›Full record

ReviewMolecular and cellular biology2013

EKLF/KLF1, a tissue-restricted integrator of transcriptional control, chromatin remodeling, and lineage determination.

Yvette Y Yien, James J Bieker

Registry-linked trialAbstract readReview
In one paragraph

Review in Molecular and cellular biology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06440603 (Erythroid Krüppel Like Factor), which is not on this map. Cited by 55 papers.

0numbers the graph read from it
0cells of the map it votes in
55citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06440603 not yet recruitingnot on this mapstarted 2024, after this paper: background citation

Erythroid Krüppel Like Factor (EKLF) Gene Expression in β-thalassemia Patients

TypeobservationalSponsorRofaida Hassan AhmedRan2024 to 2027Enrolled150Conditionsβ-thalassemiaArmsPCR
3 · Its place in the literature

Who cites it

55 citing papers in PubMed.

  1. Article
  2. Article
  3. Integrative single-cell RNA-seq and ATAC-seq identifies transcriptional and epigenetic blueprint guiding osteoclastogenic trajectory.Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research · 2025
    Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. Article
  18. Article
  19. AMolecular and cellular biology · 2020
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Yvette Y YienDepartment of Developmental and Regenerative Biology, Mount Sinai School of Medicine, New York, New York, USA.
James J Bieker

Funding

Function of Putative Determinant in HematopoiesisR01DK046865 · NIDDK · MOUNT SINAI SCHOOL OF MEDICINE OF NYU · PI JAMES J BIEKER · 1993 to 2026
$11.2M
Bipotential lineage determination by EKLFR01DK077822 · NIDDK · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI BIEKER, JAMES J · 2008 to 2012
$1.7M
Redirecting hemoglobin expression during Human ES Cell differentiationRC1DK086200 · NIDDK · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI BIEKER, JAMES J · 2010 to 2010
$658k
NIDDK NIH HHS R01 DK046865NIDDK NIH HHS R01 DK077822NIDDK NIH HHS RC1 DK086200
6 · The paper itself

Abstract

Erythroid Krüppel-like factor (EKLF or KLF1) is a transcriptional regulator that plays a critical role in lineage-restricted control of gene expression. KLF1 expression and activity are tightly controlled in a temporal and differentiation stage-specific manner. The mechanisms by which KLF1 is regulated encompass a range of biological processes, including control of KLF1 RNA transcription, protein stability, localization, and posttranslational modifications. Intact KLF1 regulation is essential to correctly regulate erythroid function by gene transcription and to maintain hematopoietic lineage homeostasis by ensuring a proper balance of erythroid/megakaryocytic differentiation. In turn, KLF1 regulates erythroid biology by a wide variety of mechanisms, including gene activation and repression by regulation of chromatin configuration, transcriptional initiation and elongation, and localization of gene loci to transcription factories in the nucleus. An extensive series of biochemical, molecular, and genetic analyses has uncovered some of the secrets of its success, and recent studies are highlighted here. These reveal a multilayered set of control mechanisms that enable efficient and specific integration of transcriptional and epigenetic controls and that pave the way for proper lineage commitment and differentiation.

Indexed as

AnimalsCell LineageChromatin Assembly and DisassemblyGene Expression RegulationHumansKruppel-Like Transcription FactorsPromoter Regions, GeneticProtein Processing, Post-TranslationalProtein StabilityZinc Fingerserythroid Kruppel-like factorKruppel-Like Transcription Factors

Identifiers

PMID23090966
PMCPMC3536305

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.